Layered bionanocomposites as carrier for procainamide

International Journal of Pharmaceutics

Volumn 388, Issue 1-2, 2010, Pages 280-286

  Kevadiya, Bhavesh D ^a   Joshi, Ghanshyam V ^a   Bajaj, Hari C ^a  

^a CSIR CENTRAL SALT AND MARINE CHEMICALS RESEARCH INSTITUTE   (India)

Author keywords

Control release; Montmorillonite (MMT); Nanocomposites; Procainamide hydrochloride (PA)

Indexed keywords

ALGINIC ACID; CHITOSAN; MONTMORILLONITE; NANOCOMPOSITE; PROCAINAMIDE;

ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; ENCAPSULATION; IN VITRO STUDY; INFRARED SPECTROSCOPY; ISOTHERM; MATERIAL COATING; PH; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY; SUSTAINED DRUG RELEASE; TEMPERATURE; X RAY DIFFRACTION;

ALGINATES; ANTI-ARRHYTHMIA AGENTS; BENTONITE; CHITOSAN; DELAYED-ACTION PREPARATIONS; DIFFUSION; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; EXCIPIENTS; GLUCURONIC ACID; HEXURONIC ACIDS; INTESTINAL SECRETIONS; NANOCOMPOSITES; PROCAINAMIDE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; X-RAY DIFFRACTION;

EID: 76549104589     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.01.002     Document Type: Article

References (33)

1. An J., Geib S.J., and Rosi N.L. Cation-triggered drug release from a porous zinc-adeninate metal-organic framework. J. Am. Chem. Soc. 131 (2009) 8376-8377
2. Bergaya F., Theng B.K.G., and Lagaly G. Handbook of Clay Science. 1st edition (2006), Elsevier Publication, Amsterdam
3. Dai Y.N., Li P., Zhang J.P., Wang A.Q., and Wei Q. A novel pH sensitive N-succinyl chitosan/alginate hydrogel bead for nifedipine delivery. Biopharm. Drug Dispos. 29 (2008) 173-184
4. Danielly J., De Jong R., Radke-Mitchell L.C., and Uprichard A.C.G. Procainamide-associated blood dyscrasias. Am. J. Cardiol. 74 (1994) 1179-1180
5. Depan D., Kumar A.P., and Singh R.P. Cell proliferation and controlled drug release studies of monohybrids based on chitosan-g-lactic acid and montmorillonite. Acta Biomater. 5 (2009) 93-100
6. Denkbas E.B., and Ottenbrite R.M. Perspectives on chitosan drug delivery systems based on their geometries. J. Bio. Comp. Polym. 21 (2006) 351-368
7. Dong Y., and Feng S.S. Poly(d,l-lactide-co-lycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs. Biomaterials 26 (2005) 6068-6076
8. Ellenbogen K.A., Wood M.A., and Gilligan D.M. Intravenous procainamide. Cardiol. Elect. Rev. 2 (1998) 179-181
9. Gerstl Z., Nasser A., and Mingelgrin U. Controlled release of pesticides into water from clay-polymer formulations. J. Agric. Food Chem. 46 (1998) 3803-3809
10. Joshi G.V., Kevadiya B.D., Patel H.A., Bajaj H.C., and Jasra R.V. Montmorillonite as a drug delivery system: intercalation and in vitro release of Timolol maleate. Int. J. Pharm. 374 (2009) 53-57
11. 1 as drug carrier. Appl. Clay Sci. 45 (2009) 248-253
12. Joshi G.V., Patel H.A., Bajaj H.C., and Jasra R.V. Intercalation and controlled release of vitamin B6 from montmorillonite-vitamin B6 hybrid. Colloid Polym. Sci. 287 (2009) 1071-1076
13. 6. J. Biomater. Appl. (2009) 10.1177/0885328208344003
14. Korsmeyer R.W., Gurny R., Doelker E., Buri P., and Peppas N.A. Mechanisms of solute release from porous hydrophilic polymers. Int. J. Pharm. 15 (1983) 25-35
15. Lee B.H., Subramanian S.Y., Lin X., and Nelson W.G. Procainamide is a specific inhibitor of DNA methyltransferase-I. J. Biol. Chem. 280 (2005) 40749-40756
16. Lin F.H., Lee Y.H., Jian C.H., Wong J.M., Shieh M.J., and Wang C.Y. A study of purified montmorillonite intercalated with 5-fluorouracil as drug carrier. Biomaterials 23 (2002) 1981-1987
17. Lin F.H., Chen C.H., Winston T.K., and Kuo C.T. Modified montmorillonite as vector for gene delivery. Biomaterials 27 (2006) 3333-3338
18. Manuel Fernandez-Perez M., Villafranca-Sanchez E., González-Pradas F., Martinez-Lopez, and Flores-Cespedes F. Controlled release of carbofuran from an alginate-bentonite formulation: water release kinetics and soil mobility. J. Agric. Food Chem. 48 (2000) 938-943
19. Markland P., Amidon G.L., and Yang V.C. Modified polypeptides containing gama-benzyl glutamic acid as drug delivery platforms. Int. J. Pharm. 178 (1999) 183-192
20. Mohanambe L., and Vasudevan S. Anionic clays containing anti-inflammatory drug molecules: comparison of molecular dynamics simulation and measurements. J. Phys. Chem. B 109 (2005) 15651-15658
21. Park J.K., Choy Y.B., Oh J.M., Kim J.Y., Hwang S.J., and Choy. Controlled release of donepezil intercalated in smectite clays. Int. J. Pharm. 359 (2008) 198-204
22. Pasparakis G., and Bouropoulos N. Swelling studies and in vitro release of verapamil from calcium alginate and calcium alginate-chitosan beads. Int. J. Pharm. 323 (2006) 34-42
23. Patel H.A., Somani R.S., Bajaj H.C., and Jasra R.V. Nanoclays for polymer nanocomposites, paints, inks, greases and cosmetics formulations, drug delivery vehicle and waste water treatment. Bull. Mater. Sci. 29 (2006) 133-145
24. Patel H.A., Somani R.S., Bajaj H.C., and Jasra R.V. Synthesis and characterization of organic bentonite using Gujarat and Rajasthan clays. Curr. Sci. 92 (2007) 1004-1009
25. Patel H.A., Somani R.S., Bajaj H.C., and Jasra R.V. Preparation and characterization of phosphonium montmorillonite with enhanced thermal stability. Appl. Clay Sci. 35 (2007) 194-200
26. Pongjanyakul T. Alginate-magnesium aluminum silicate films: importance of alginate blocks structures. Int. J. Pharm. 365 (2009) 100-108
27. Shilpa A., Agrawal S.S., and Ray A.R. Controlled delivery of drugs from alginate matrix. J. Macromol. Sci. C Polym. Rev. C 43 (2003) 187-221
28. Sintov A., and Levy R.J. Polymeric drug delivery of enzymatically degradable pendant agents: peptidyl-linked procainamide model system studies. Int. J. Pharm. 146 (1997) 55-62
29. Sun B., Ranganathan B., and Feng S.S. Multifunctional poly(d,l-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer. Biomaterials 29 (2008) 475-486
30. Thaned P., and Satit P. Sodium AL-magnesium aluminum silicate composite gels: characterization of flow behavior, micro-viscosity, and drug diffusivity. AAPS Pharm. Sci. Technol. 8 (2007) E1-E7
31. Tonnesen H.H., and Karlsen J. Alginate in drug delivery systems. Drug Dev. Ind. Pharm. 28 (2002) 621-630
32. Wang X., Du Y., and Lueo J. Biopolymer/montmorillonite nanocomposite: preparation, drug-controlled release property and cytotoxicity. Nanotechnology (2008) 10.1088/0957-4484/19/6/065707
33. Zheng J.P., Luan L., Wang H.Y., Xi L.F., and Yao K.D. Study on ibuprofen/montmorillonite intercalation composites as drug release system. Appl. Clay Sci. 36 (2007) 297-301